Shuxuan Shao

Shuxuan Shao

Auto-generated profile, based on publicly available information

Shuxuan Shao

Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Bio‐Sensing and Chemometrics, College of Biology Hunan University Changsha 410082 P. R. China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
ZJZeyidan Jiapaer
Zeyidan Jiapaer
LZLingying Zhang
Lingying Zhang
WMWanli Ma
Wanli Ma
HLHaoqiang Liu
Haoqiang Liu
CLChengyu Li
Chengyu Li
SSShuxuan Shao
Shuxuan Shao
Colorectal cancer is one of the most common malignancies causing the majority of cancer-related deaths. There is an urgent need to develop new anticancer modalities. Recently, efforts have been made to turn clinically approved drugs into anticancer agents in specific tumor microenvironments via NPs. Disulfiram (DSF) as an effective copper (Cu2+)-dependent anti-tumour drug, which has been more widely used in antitumor research. Here, we constructed a novel therapeutic nanoplatforms, DSF@CuS, by encapsulating DSF in hollow CuS NPs to enable in situ chemoselective activation of DSF and hyperthermal amplified chemotherapy. The anticancer effect of DSF was enhanced by the thermal energy generated under NIR irradiation through the intrinsic photothermal conversion of CuS. As a result, significant apoptosis was induced in vitro, and tumor elimination was achieved in vivo. Collectively, DSF@CuS combined with photothermal therapy can significantly promote the apoptosis of CT26 colorectal cancer cells both in vitro and in vivo, providing a potential theoretical agent for the treatment of colorectal cancer.

23 June 2023 in Advanced Therapeutics
Verified
Journal Article
Closed access
SSShuxuan Shao
Shuxuan Shao
WWWanfeng Wu
Wanfeng Wu
FMFanxing Meng
Fanxing Meng
MDMengjiao Duan
Mengjiao Duan
MZMinwei Zhang
Minwei Zhang

1 June 2022 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
HLHaoqiang Liu
Haoqiang Liu
ZJZeyidan Jiapaer
Zeyidan Jiapaer
FMFanxing Meng
Fanxing Meng
WWWanfeng Wu
Wanfeng Wu
CHChengyi Hou
Chengyi Hou
MZMinwei Zhang
Minwei Zhang
Background: Natural bioactive substances have been widely studied for their superior anti-tumor activity and low toxicity. However, natural bioactive substances suffer from poor water-solubility and poor stability in the physiological environment. Therefore, to overcome the drawbacks of natural bioactive substances in tumor therapy, there is an urgent need for an ideal nanocarrier to achieve high bioactive substance loading with low toxicity. Materials and Methods: Face-centered cubic hollow mesoporous Prussian Blue (HMPB) NPs were prepared by stepwise hydrothermal method. Among them, PVP served as a protective agent and HCl served as an etching agent. Firstly, MPB NPs were obtained by 0.01 M HCl etching. Then, the highly uniform dispersed HMPB NPs were obtained by further etching with 1 M HCl. Results: In this work, we report a pH-responsive therapeutic nanoplatform based on HMPB NPs. Surprisingly, as-prepared HMPB NPs with ultra-high bioactive substances loading capacity of 329 μg mg− 1 owing to the large surface area (131.67 m2 g− 1) and wide internal pore size distribution (1.8– 96.2 nm). Moreover, with the outstanding photothermal conversion efficiency of HMPB NPs (30.13%), natural bioactive substances were released in the tumor microenvironment (TME). [email protected] B2 achieved excellent synergistic therapeutic effects of photothermal therapy (PTT) and chemotherapy (CT) in vivo and in vitro without causing any extraneous side effects. Conclusion: A biocompatible [email protected] B2 nanoplatform was constructed by simple physical adsorption. The in vitro and in vivo experiment results demonstrated that the synergy of PTT/CT provided excellent therapeutic efficiency for cervical cancer without toxicity. Altogether, as-designed nanomedicines based on natural bioactive substances may be provide a promising strategy for cancer therapy. Graphical Abstract: